Hongxiang Yu

696 citations
27 papers · 533 indexed · h-index 10
Topics
Parkinson's Disease Mechanisms and Treatments (5 papers)Pluripotent Stem Cells Research (5 papers)CRISPR and Genetic Engineering (3 papers)
Journals
SHILAP Revista de lepidopterologíaImmunityPLoS ONE

In The Last Decade

Hongxiang Yu

26 papers receiving 533 citations

Peers

Hongxiang Yu
Comparison fields: 5 of 91
  • Immunology 189
  • Molecular Biology 188
  • Oncology 71
  • Physiology 54
  • Cancer Research 46
Replace Zaridatul Aini Ibrahim with:
Zaridatul Aini Ibrahim Malaysia
Tatyana Sevastyanova Germany
Thiranut Jaroonwitchawan Thailand
Ran An China
Tingyi Sun China
Meimei Wu China
Karolyn G. Lahue United States
Weiguo Wan China
Ali Akbar Saboor-Yaraghi Iran
Cornelia Doebis Germany
Hongxiang Yu relative to Zaridatul Aini Ibrahim Malaysia Zaridatul Aini Ibrahim's profile →
Citations per field
00.5×
Zaridatul Aini Ibrahim · 1×
Citations per year

Countries citing papers authored by Hongxiang Yu

Since Specialization
Citations

This map shows the geographic impact of Hongxiang Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongxiang Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongxiang Yu more than expected).

Fields of papers citing papers by Hongxiang Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongxiang Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongxiang Yu. The network helps show where Hongxiang Yu may publish in the future.

Co-authorship network of co-authors of Hongxiang Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Hongxiang Yu. A scholar is included among the top collaborators of Hongxiang Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongxiang Yu. Hongxiang Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 5
2 1
3 0
4 11
5 1
6 1
7 19
8 25
9 10
10 78
11 9
12 8
13 8
14 3
15 4
16 3
17 50
18 162
19 32
20 4

About Hongxiang Yu

Hongxiang Yu is a scholar working on Neurology, Neurology and Developmental Neuroscience, having authored 27 papers that have together received 533 indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (5 papers), Pluripotent Stem Cells Research (5 papers) and CRISPR and Genetic Engineering (3 papers). The work is most often cited by research in Immunology (189 citations), Biological Psychiatry (13 citations) and Molecular Medicine (17 citations). Hongxiang Yu has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Bei Zhang, Yingying Han, Brian Kidd, Jun Huang, Evan W. Newell, Michael S. Kuhns, Mark M. Davis, Yueh-hsiu Chien, Xun Zeng and Casey T. Weaver. Their work appears in journals such as SHILAP Revista de lepidopterología, Immunity and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026